首页 News 正文

On Thursday, weight loss drug giant Novo Nordisk held a earnings conference call, promising to further adopt a price reduction strategy in the US market. The company's Chief Financial Officer, Karsten Munk Knudsen, stated that due to huge sales and fierce competition, Novo Nordisk plans to lower the price of its weight loss drug Wegovy in the United States.
您需要登录后才可以回帖 登录 | 立即注册

本版积分规则

海角七号 注册会员
  • 粉丝

    0

  • 关注

    1

  • 主题

    29